Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
KaliVir Immunotherapeutics has successfully completed the first cohort of its STEALTH-001 Phase 1/1b trial evaluating VET3-TGI in patients with advanced solid tumors.
KaliVir Immunotherapeutics has dosed the first patient in a Phase I/Ib trial of VET3-TGI, an oncolytic immunotherapy for advanced solid tumors.
KaliVir Immunotherapeutics received FDA clearance for its IND application for VET3-TGI, an oncolytic immunotherapy, to treat advanced solid tumors.